Nicotinamide Adenine Dinucleotide 1g & Retatrutide : A British Update
The recent interest in NAD+ supplementation, particularly at a high dosage of one gram, continues to rise within the UK healthcare community. Concurrently, attention is focused on Retatrutide, a novel GLP-1 receptor agonist being viewed by many as a potential replacement to Tirzepatide. At presen